CSF2 and cancer: Other factors such as GM-CSF promote myeloid cell development and maturation and dendritic cell differentiation while reducing VEGF activity and angiogenesis by inducing monocyte secretion of soluble VEGFR-1, which are advantageous in cancer settings to slow metastasis.33